Edgewise Therapeutics

EWTX | NASDAQ | 0 Obserwujący

$14.30

-1.17%

-$0.17

Obserwuj

Overview Metrics Financials

Fair Price

$58.34

Undervalued by 73.2%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Edgewise Therapeutics, Inc. is a biotechnology company based in the United States that focuses on the development of therapeutic drugs for rare genetic diseases. The company specializes in innovative approaches in gene therapy and targets conditions such as Duchenne muscular dystrophy and other muscle disorders. Edgewise Therapeutics uses advanced scientific methods to develop drugs with the potential to significantly improve the quality of life for patients suffering from these serious and currently challenging-to-treat conditions.

Feed

There are no posts to show right now.

Edgewise Therapeutics

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?